On Demand 2019 New Horizons in Chronic Rhinosinusitis (MOC)

Price: $25 members, $35 non-members

This session will provide a foundation for exploring newer medical, surgical and biologic therapies for chronic rhinosinusitis (CRS) with and without nasal polyps. Etiology, diagnosis and management will be reviewed.

You can earn up to 1.5 AMA PRA Category 1 Credits™, and up to 1.5 MOC Part II Self-Assessment credits. 

  • New Understanding in the Etiology and Pathogenesis of Chronic Rhinosinusitis
    Jonathan A. Bernstein, MD, FACAAI
  • What's New in Medical and Surgical Management of CRS
    Joseph Han, MD
  • The Coming Revolution of Biologics in CRS
    Anju T. Peters, MD

Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Of the AMA PRA Category 1 Credits™ listed above, the ABAI has designated a maximum of 1.5 credits as meeting the requirements for MOC Part II Self-Assessment.

Target Audience

  • Practicing allergist/immunologists
  • Allergy/immunology Fellows-in-Training
  • Physician assistants
  • Nurses and advanced practice nurses
  • Allied health professionals
  • Primary care physicians
  • Other medical professionals

Learning Objectives

Objective 1:
Recognize CRS as a clinical issue and develop an improved knowledge of the etiology and pathogenesis.
Objective 2:
Be able to develop a management plan for a patient with CRS based on new medical and surgical management options.
Objective 3:
Appreciate the involvement of Type 2 inflammation in CRS and the role biologics may play in management.

Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma & Immunology (ACAAI) policy, the College must identify and resolve conflicts of interest for all individuals responsible for the development, management, presentation, and/ or evaluation relevant to a CME activity. Disclosed information is reviewed in advance in order to manage and resolve any potential conflicts of interest. Disclosure in no way implies that the information presented is biased or of lesser quality; it is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations.

Specific disclosure information for the 2019 Annual Meeting is available online and via the meeting app.

Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Attendance
  • 1.50 CBRN
  • 1.50 MOC
Course opens: 
12/02/2019
Course expires: 
12/01/2021
Cost:
$35.00
Rating: 
5

Jonathan A. Bernstein, MD, FACAAI
 
Joseph Han, MD
 
Anju T. Peters, MD

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Attendance
  • 1.50 CBRN
  • 1.50 MOC

Price

Cost:
$35.00
Please login or create an account to take this course.